Divi's Laboratories Statistics

Total Valuation

Divi's Laboratories has a market cap or net worth of INR 1.55 trillion. The enterprise value is 1.52 trillion.

Market Cap	1.55T
Enterprise Value	1.52T

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Aug 2, 2024

Share Statistics

Divi's Laboratories has 265.47 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	265.47M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	49.16%
Owned by Institutions (%)	26.81%
Float	122.26M

Valuation Ratios

The trailing PE ratio is 84.55 and the forward PE ratio is 69.27. Divi's Laboratories's PEG ratio is 2.69.

PE Ratio	84.55
Forward PE	69.27
PS Ratio	18.02
PB Ratio	11.32
P/TBV Ratio	11.32
P/FCF Ratio	326.76
P/OCF Ratio	n/a
PEG Ratio	2.69

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.18, with an EV/FCF ratio of 319.20.

EV / Earnings	82.58
EV / Sales	17.60
EV / EBITDA	59.18
EV / EBIT	69.58
EV / FCF	319.20

Financial Position

The company has a current ratio of 7.24, with a Debt / Equity ratio of 0.00.

Current Ratio	7.24
Quick Ratio	4.48
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.02
Interest Coverage	726.33

Financial Efficiency

Return on equity (ROE) is 13.91% and return on invested capital (ROIC) is 10.31%.

Return on Equity (ROE)	13.91%
Return on Assets (ROA)	9.12%
Return on Capital (ROIC)	10.31%
Revenue Per Employee	8.84M
Profits Per Employee	1.88M
Employee Count	9,741
Asset Turnover	0.58
Inventory Turnover	1.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.01% in the last 52 weeks. The beta is 0.37, so Divi's Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+57.01%
50-Day Moving Average	5,950.38
200-Day Moving Average	4,835.18
Relative Strength Index (RSI)	43.77
Average Volume (20 Days)	562,808

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Divi's Laboratories had revenue of INR 86.14 billion and earned 18.36 billion in profits. Earnings per share was 69.15.

Revenue	86.14B
Gross Profit	49.38B
Operating Income	21.79B
Pretax Income	25.28B
Net Income	18.36B
EBITDA	25.61B
EBIT	21.79B
Earnings Per Share (EPS)	69.15

Full Income Statement

Balance Sheet

The company has 36.02 billion in cash and 80.00 million in debt, giving a net cash position of 35.94 billion or 135.38 per share.

Cash & Cash Equivalents	36.02B
Total Debt	80.00M
Net Cash	35.94B
Net Cash Per Share	135.38
Equity (Book Value)	137.17B
Book Value Per Share	516.40
Working Capital	80.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.48 billion and capital expenditures -11.73 billion, giving a free cash flow of 4.75 billion.

Operating Cash Flow	16.48B
Capital Expenditures	-11.73B
Free Cash Flow	4.75B
FCF Per Share	17.89

Full Cash Flow Statement

Margins

Gross margin is 57.33%, with operating and profit margins of 25.30% and 21.31%.

Gross Margin	57.33%
Operating Margin	25.30%
Pretax Margin	29.35%
Profit Margin	21.31%
EBITDA Margin	29.73%
EBIT Margin	25.30%
FCF Margin	5.51%

Dividends & Yields

This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 0.51%.

Dividend Per Share	30.00
Dividend Yield	0.51%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	43.36%
Buyback Yield	-0.03%
Shareholder Yield	0.48%
Earnings Yield	1.18%
FCF Yield	0.31%

Dividend Details

Stock Splits

The last stock split was on September 23, 2015. It was a forward split with a ratio of 2.

Last Split Date	Sep 23, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a